The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of cancellation of admission to AIM

13 Nov 2017 07:00

RNS Number : 2415W
Touchstone Innovations PLC
13 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

13 November 2017

Touchstone Innovations plc

 

Notice of cancellation of admission to trading on AIM

 

Further to the announcement released on 18 October 2017 by IP Group plc ("IP Group") declaring the IP Group offer (the "Offer") wholly unconditional in all respects, Touchstone Innovations plc ("Touchstone" or the "Company") notifies its shareholders that, at the request of IP Group, an application has been made to London Stock Exchange plc to cancel the trading facility in the ordinary shares in the capital of the Company ("Ordinary Shares") on AIM with effect from 7:00am on 11 December 2017.

The cancellation of trading in the Ordinary Shares will significantly reduce the liquidity and marketability of any Ordinary Shares and, as previously stated, the Board of Touchstone recommends that Touchstone shareholders who have not yet accepted the Offer now do so promptly.

Those Touchstone shareholders who accept the Offer will receive their new shares in IP Group as consideration for their Touchstone shares at an earlier date than they would as part of the compulsory acquisition procedure.

IP Group has announced that the Offer will remain open until further notice and that not less than 14 calendar days' notice will be given in respect of the closure of the Offer.

If you are a Touchstone shareholder and in any doubt as to the action you should take, you are recommended to seek your own financial advice immediately from your stockbroker, bank manager, solicitor, accountant, fund manager or other appropriate independent financial adviser authorised under the Financial Services and Markets Act 2000, as amended if you are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.

For further information contact:

Touchstone Innovations plc

020 3053 8834

Russ Cummings, Chief Executive Officer

William Rayner, General Counsel and Company Secretary

Jon Davies, Director of Communications

Instinctif Partners

020 7457 2020

Adrian Duffield/Mel Toyne-Sewell/Chantal Woolcock

J.P. Morgan Cazenove (Nominated adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

RBC Capital Markets (Joint Corporate Broker)

020 7653 4000

Marcus Jackson

 

Further Information

J.P. Morgan Limited, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised and regulated in the United Kingdom by the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Touchstone Innovations plc and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Touchstone Innovations plc for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, or for providing advice in relation to any matter referred to herein.

RBC Capital Markets is the business name used by RBC Europe Limited, which is authorised in the United Kingdom by the Prudential Regulation Authority ("PRA") and regulated by the Financial Conduct Authority and the PRA and is a subsidiary of the Royal Bank of Canada. RBC is acting as Corporate Broker to the Company.

 

Ends

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPFEFDSXFFF
Date   Source Headline
26th Oct 20077:24 amPRNGBP30m Placing
27th Sep 20077:04 amRNSInvestment in EVO Electric
27th Sep 20077:00 amPRNFinal Results
24th Sep 20072:44 pmRNSThe Engineer Awards
12th Sep 20078:00 amPRNNotice of Preliminary Results
31st Aug 20079:00 amRNSInvestment in MVL
7th Aug 20079:00 amRNSionscope raises funds
3rd Aug 200710:25 amRNSInvestment in Veryan Medical
3rd Aug 20078:00 amRNSInvestment in Veryan Medical
1st Aug 20075:31 pmRNSInvestment in Nexeon Ltd
30th Jul 20078:00 amRNSInvestment in Acrobot Ltd
11th Jul 20079:37 amRNSInvestment in AML
6th Jul 20078:10 amRNSInvestment in NanoBioDesign
28th Jun 20077:02 amRNSInvestment in QuantaSol
25th Jun 200710:00 amRNSCall For Recycling Inventions
20th Jun 200711:21 amRNSInvestment in PolyTherics
14th Jun 20072:31 pmRNSInvestment in Midaz Lasers
6th Jun 20073:11 pmRNSPSE Wins MacRobert Award
5th Jun 200711:03 amRNSPSE - Awards Finalist
23rd May 20078:00 amRNSInvestment in IXICO Ltd
11th May 200710:00 amRNSInvestment in Veryan Medical
9th May 200710:04 amRNSMDi Licensing Deal
27th Apr 20077:01 amRNSLaunch of Funding Programme
27th Apr 20077:01 amRNSInterim Results
30th Mar 20078:00 amRNSInvestment in Cell Medica
27th Mar 200710:22 amRNSStormBio Licensing Deal
23rd Mar 20078:00 amRNSNotice of Results
22nd Mar 200711:53 amRNSHolding(s) in Company
16th Mar 200710:44 amRNSHolding(s) in Company
15th Mar 20079:00 amRNSIncubation of Stoneglass
12th Mar 20078:00 amRNSIonscope Sells First Products
8th Mar 20079:20 amRNSHolding(s) in Company
7th Mar 20078:00 amRNSChinese Strategic Partnership
13th Feb 20078:00 amRNSIncubation of Rubber-Regen
9th Feb 20073:05 pmRNSHolding(s) in Company
8th Feb 20072:58 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSInvestment in ATT Ltd
29th Jan 20077:01 amRNSInvestment in Circassia
25th Jan 200712:59 pmRNSResult of AGM
12th Jan 20079:00 amRNSInvestment in Equinox Pharma
21st Dec 200612:13 pmRNSTotal Voting Rights
18th Dec 20064:53 pmRNSHolding(s) in Company
8th Dec 20067:00 amRNSAnnual Report and Accounts
21st Nov 20067:01 amRNSDirector/PDMR Shareholding
16th Nov 20067:01 amRNSBAE Systems Contract
16th Nov 20067:01 amRNSFinal Results
2nd Nov 20068:00 amRNSImperial BioIncubator
26th Oct 20067:01 amRNSNotice of Results
23rd Oct 20064:17 pmRNSDisposal
18th Oct 20067:00 amRNSLow Carbon Seed Fund

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.